When GLP-1 receptor agonists are used with insulin or sulfonylureas, the risk of hypoglycaemia increases, and dose reductions of these medications may be necessary
Women under 40 Premenopausal women on GLP-1 medications face hair loss primarily from telogen effluvium and nutritional depletion
Retatrutide is a once-weekly injection that mimics three hormones involved in appetite, blood sugar, and how the body uses energy: GLP-1: lowers appetite and blood sugar GIP: lowers appetite and blood sugar Glucagon: increases energy expenditure and the breakdown of stored fat, including fat in the liver The glucagon component is what separates retatrutide from semaglutide, which mimics one hormone (GLP-1), and tirzepatide, which mimics two (GLP-1 and GIP)
While these medications are available without a prescription, its still a good idea to consult your healthcare provider before using them alongside GLP-1 medications to ensure theyre safe and wont interact with your treatment
Patients do not need to worry about the disposal of sharps